enVVeno Medical Income Statement (2017-2026) | NVNO

Income Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)
1.09M1.23M1.78M1.55M3.07M2.49M2.80M3.60M4.21M2.80M2.98M3.05M2.83M2.86M3.51M2.56M2.89M2.58M1.95M2.11M
Selling, General & Administrative (Quarter)
1.30M1.48M7.21M3.78M3.91M3.66M3.66M3.20M2.60M2.55M3.30M2.45M2.63M3.31M3.19M2.40M4.16M2.30M2.06M1.95M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
2.39M2.71M8.99M5.33M6.99M6.15M6.46M6.80M6.81M5.35M6.28M5.50M5.45M6.17M6.70M4.95M7.05M4.88M4.01M4.06M
Operating Income (Quarter)
-2.39M-2.71M-8.99M-5.33M-6.99M-6.15M-6.46M-6.80M-6.81M-5.35M-6.28M-5.50M-5.45M-6.17M-6.70M-4.95M-7.05M-4.88M-4.01M-4.06M
EBIT (Quarter)
-2.39M-2.71M-8.99M-5.33M-6.99M-6.15M-6.46M-6.80M-6.81M-5.35M-6.28M-5.50M-5.45M-6.17M-6.70M-4.95M-7.05M-4.88M-4.01M-4.06M
Non-operating items
Non Operating Investment Income (Quarter)
-0.11M-0.02M0.18M0.28M0.13M0.16M-0.10M0.05M0.01M-0.12M-0.20M-0.08M-0.04M-0.08M-0.04M
Interest & Investment Income (Quarter)
0.01M0.01M0.01M0.04M0.07M0.04M0.04M0.04M0.04M0.05M0.06M0.07M0.09M0.16M0.22M0.20M0.17M0.10M0.02M
Other Non Operating Income (Quarter)
0.00M0.31M-0.28M
Non Operating Income (Quarter)
0.01M0.32M0.33M0.01M-0.08M0.05M0.28M0.41M0.34M0.35M0.63M0.51M0.50M0.53M0.47M0.45M0.35M0.34M0.28M0.21M
Net income details
EBT (Quarter)
-2.38M-2.70M-8.99M-5.33M-6.95M-6.08M-6.42M-6.75M-6.78M-5.30M-6.23M-5.44M-5.38M-6.08M-6.54M-4.74M-6.85M-4.71M-3.91M-4.04M
Profit After Tax (Quarter)
-2.38M-2.39M-8.99M-5.33M-7.06M-6.10M-6.18M-6.39M-6.47M-5.00M-5.65M-4.99M-4.96M-5.64M-6.23M-4.50M-6.69M-4.54M-3.74M-3.85M
Income from Continuing Operations (Quarter)
-2.38M-2.70M-8.99M-5.33M-6.95M-6.08M-6.42M-6.75M-6.78M-5.30M-6.23M-5.44M-5.38M-6.08M-6.54M-4.74M-6.85M-4.71M-3.91M-4.04M
Consolidated Net Income (Quarter)
-2.38M-2.70M-8.99M-5.33M-6.95M-6.08M-6.42M-6.75M-6.78M-5.30M-6.23M-5.44M-5.38M-6.08M-6.54M-4.74M-6.85M-4.71M-3.91M-4.04M
Income towards Parent Company (Quarter)
-2.38M-2.70M-8.99M-5.33M-6.95M-6.08M-6.42M-6.75M-6.78M-5.30M-6.23M-5.44M-5.38M-6.08M-6.54M-4.74M-6.85M-4.71M-3.91M-4.04M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-2.38M-2.39M-8.99M-5.33M-6.95M-6.08M-6.42M-6.75M-6.78M-5.30M-6.23M-5.44M-5.38M-6.08M-6.54M-4.74M-6.85M-4.71M-3.91M-4.04M
Additional items
EPS (Basic) (Quarter)
-0.28-0.26-0.94-0.47-0.63-0.54-0.55-0.57-0.58-0.45-0.32-0.31-0.31-0.35-43.56-7.75-0.33-0.23-32.28-5.89
EPS (Weighted Average and Diluted) (Quarter)
-0.63-0.54-0.55-0.57-0.58-0.45-0.32-0.31-0.31-0.35-43.56-7.75-0.33-0.23-32.28-5.89
Shares Outstanding (Weighted Average) (Quarter)
0.01M7.84M8.68M11.23M11.23M11.23M11.23M11.23M11.23M11.23M12.30M16.06M16.07M16.06M0.49M0.58M20.35M20.16M0.59M0.65M
Shares Outstanding (Diluted Average) (Quarter)
11.23M11.23M11.23M11.23M11.23M11.23M12.30M16.06M16.07M16.06M0.49M0.58M20.35M20.16M0.59M0.65M
EBITDA (Quarter)
-2.39M-2.71M-8.99M-5.33M-6.99M-6.15M-6.46M-6.80M-6.81M-5.35M-6.28M-5.50M-5.45M-6.17M-6.70M-4.95M-7.05M-4.88M-4.01M-4.06M
Interest Expenses (Quarter)
867.00
Shares Outstanding (Quarter)
8.51M9.47M9.47M9.47M9.47M9.47M9.47M9.47M9.47M9.47M0.38M13.33M13.33M17.54M0.50M0.50M19.25M20.22M0.66M0.66M